XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Our two reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources.
The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our Military services business, primarily our T-2017 East Region contract, as well as the operations of our PBM business.
The CenterWell segment includes our pharmacy, primary care, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs.
Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics.
In addition, our CenterWell intersegment revenues include revenues earned by certain owned providers derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.
We present our condensed consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $5.6 billion and $5.7 billion for the three months ended September 30, 2024 and 2023, respectively. For the nine months ended September 30, 2024 and 2023, these amounts were $14.1 billion and $14.7 billion respectively. In
addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our primary care and pharmacy operations, are included with benefits expense. The amount of this expense was $32 million and $35 million for the three months ended September 30, 2024 and 2023, respectively, and $96 million and $102 million for the nine months ended September 30, 2024 and 2023, respectively.
Other than those described previously, the accounting policies of each segment are the same. For additional information regarding our accounting policies refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2023 Form 10-K. Transactions between reportable segments primarily consist of sales of products and services rendered by our CenterWell segment, primarily pharmacy, primary care, and home solutions, to our Insurance segment customers. Intersegment sales and expenses are recorded primarily at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below.
Our segment results were as follows for the three and nine months ended September 30, 2024 and 2023:
InsuranceCenterWellEliminations/
Corporate
Consolidated
Three months ended September 30, 2024(in millions)
External revenues
Premiums:
Individual Medicare Advantage$21,856 $— $— $21,856 
Group Medicare Advantage1,913 — — 1,913 
Medicare stand-alone PDP721 — — 721 
Total Medicare24,490 — — 24,490 
Commercial fully-insured85 — — 85 
Specialty benefits238 — — 238 
Medicare Supplement217 — — 217 
State-based contracts and other2,921 — — 2,921 
Total premiums27,951 — — 27,951 
Services revenue:
Home solutions— 326 — 326 
Primary care— 319 — 319 
Pharmacy solutions— 232 — 232 
Commercial ASO12 — — 12 
Military services and other214 — — 214 
Total services revenue226 877 — 1,103 
Total external revenues 28,177 877 — 29,054 
Intersegment revenues
Services1,463 (1,464)— 
Products— 2,701 (2,701)— 
Total intersegment revenues4,164 (4,165)— 
Investment income192 — 151 343 
Total revenues28,370 5,041 (4,014)29,397 
Operating expenses:
Benefits25,319 — (199)25,120 
Operating costs2,595 4,602 (3,858)3,339 
Depreciation and amortization182 57 (29)210 
Total operating expenses28,096 4,659 (4,086)28,669 
Income from operations274 382 72 728 
Interest expense— 167 169 
Other income, net— — (92)(92)
Income (loss) before income taxes and equity in net earnings 274 380 (3)651 
Equity in net losses(1)(15)— (16)
Segment earnings (loss)$273 $365 $(3)$635 
Net loss attributable to noncontrolling interests— — — — 
Segment earnings (loss) attributable to Humana$273 $365 $(3)$635 
InsuranceCenterWellEliminations/
Corporate
Consolidated
Three months ended September 30, 2023(in millions)
External revenues
Premiums:
Individual Medicare Advantage$19,637 $— $— $19,637 
Group Medicare Advantage1,695 — — 1,695 
Medicare stand-alone PDP493 — — 493 
Total Medicare21,825 — — 21,825 
Commercial fully-insured842 — — 842 
Specialty benefits252 — — 252 
Medicare Supplement185 — — 185 
State-based contracts and other1,995 — — 1,995 
Total premiums25,099 — — 25,099 
Services revenue:
Home solutions— 342 — 342 
Primary care— 214 — 214 
Pharmacy solutions— 203 — 203 
Commercial ASO55 — — 55 
Military services and other202 — — 202 
Total services revenue257 759 — 1,016 
Total external revenues 25,356 759 — 26,115 
Intersegment revenues
Services1,307 (1,308)— 
Products— 2,594 (2,594)— 
Total intersegment revenues3,901 (3,902)— 
Investment income 154 — 154 308 
Total revenues25,511 4,660 (3,748)26,423 
Operating expenses:
Benefits21,976 — (231)21,745 
Operating costs2,634 4,207 (3,570)3,271 
Depreciation and amortization179 53 (31)201 
Total operating expenses24,789 4,260 (3,832)25,217 
Income from operations722 400 84 1,206 
Interest expense— 113 114 
Other income, net— — (6)(6)
Income (loss) before income taxes and equity in net earnings 722 399 (23)1,098 
Equity in net losses— (12)— (12)
Segment earnings (loss)$722 $387 $(23)$1,086 
Net loss (income) attributable to noncontrolling interests(1)— 
Segment earnings (loss) attributable to Humana$725 $386 $(23)$1,088 
InsuranceCenterWellEliminations/
Corporate
Consolidated
Nine months ended September 30, 2024(in millions)
External revenues
Premiums:
Individual Medicare Advantage$66,519 $— $— $66,519 
Group Medicare Advantage5,840 — — 5,840 
Medicare stand-alone PDP2,409 — — 2,409 
Total Medicare74,768 — — 74,768 
Commercial fully-insured493 — — 493 
Specialty benefits717 — — 717 
Medicare Supplement620 — — 620 
State-based contracts and other7,756 — — 7,756 
Total premiums84,354 — — 84,354 
Services revenue:
Home solutions— 996 — 996 
Primary care— 882 — 882 
Pharmacy solutions— 672 — 672 
Commercial ASO44 — — 44 
Military services and other671 — — 671 
Total services revenue715 2,550 — 3,265 
Total external revenues 85,069 2,550 — 87,619 
Intersegment revenues
Services4,293 (4,296)— 
Products— 7,963 (7,963)— 
Total intersegment revenues12,256 (12,259)— 
Investment income522 — 407 929 
Total revenues85,594 14,806 (11,852)88,548 
Operating expenses:
Benefits75,752 — (469)75,283 
Operating costs7,354 13,638 (11,463)9,529 
Depreciation and amortization553 166 (88)631 
Total operating expenses83,659 13,804 (12,020)85,443 
Income from operations1,935 1,002 168 3,105 
Interest expense— 492 496 
Other expense, net— — 26 26 
Income (loss) before income taxes and equity in net losses 1,935 998 (350)2,583 
Equity in net losses(2)(55)— (57)
Segment earnings (loss)$1,933 $943 $(350)$2,526 
Net loss attributable to noncontrolling interests— — 
Segment earnings (loss) attributable to Humana$1,936 $943 $(350)$2,529 
InsuranceCenterWellEliminations/
Corporate
Consolidated
Nine Months Ended September 30, 2023(in millions)
External Revenues
Premiums:
Individual Medicare Advantage$59,195 $— $— $59,195 
Group Medicare Advantage5,192 — — 5,192 
Medicare stand-alone PDP1,677 — — 1,677 
Total Medicare66,064 — — 66,064 
Commercial fully-insured2,810 — — 2,810 
Specialty benefits758 — — 758 
Medicare Supplement546 — — 546 
State-based contracts and other5,966 — — 5,966 
Total premiums76,144 — — 76,144 
Services revenue:
Home solutions— 997 — 997 
Primary care— 605 — 605 
Pharmacy solutions— 661 — 661 
Commercial ASO190 — — 190 
Military services and other540 — — 540 
Total services revenue730 2,263 — 2,993 
Total external revenues 76,874 2,263 — 79,137 
Intersegment revenues
Services30 3,584 (3,614)— 
Products— 7,848 (7,848)— 
Total intersegment revenues30 11,432 (11,462)— 
Investment income385 — 390 775 
Total revenues77,289 13,695 (11,072)79,912 
Operating expenses:
Benefits66,096 — (484)65,612 
Operating costs7,597 12,526 (10,762)9,361 
Depreciation and amortization516 152 (90)578 
Total operating expenses74,209 12,678 (11,336)75,551 
Income from operations3,080 1,017 264 4,361 
Interest expense— 345 347 
Other expense, net— — 40 40 
Income (loss) before income taxes and equity in net losses3,080 1,015 (121)3,974 
Equity in net losses(2)(37)— (39)
Segment earnings (loss)$3,078 $978 $(121)$3,935 
Net loss (income) attributable to noncontrolling interests(1)— 
Segment earnings (loss) attributable to Humana$3,085 $977 $(121)$3,941